Broadly neutralizing antibodies: "The next thing" to treat children with HIV?

Maud Mavigner; Ann Chahroudi

doi:10.1126/scitranslmed.adi0293

Broadly neutralizing antibodies: "The next thing" to treat children with HIV?

Sci Transl Med. 2023 Jul 5;15(703):eadi0293. doi: 10.1126/scitranslmed.adi0293. Epub 2023 Jul 5.

Authors

Maud Mavigner^{1

2

3}, Ann Chahroudi^{1

2

3}

Affiliations

¹ Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
² Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
³ Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta and Emory University, Atlanta, GA 30322, USA.

PMID: 37406135
DOI: 10.1126/scitranslmed.adi0293

Abstract

Monthly treatment with two neutralizing antibodies maintained HIV suppression in almost half of children who received early antiretroviral treatment (Shapiro et al.).

Publication types

Comment

MeSH terms

Antibodies, Neutralizing / immunology
Antibodies, Neutralizing / therapeutic use
Broadly Neutralizing Antibodies* / immunology
Broadly Neutralizing Antibodies* / therapeutic use
Child
HIV Antibodies / therapeutic use
HIV Infections* / drug therapy
HIV Infections* / immunology
HIV-1*
Humans

Substances

Antibodies, Neutralizing
Broadly Neutralizing Antibodies
HIV Antibodies